MARCHF1 and pancreatic adenocarcinoma: Meanwhile, MARCH1 expression was significantly decreased in colon adenocarcinoma (COAD), LUAD, lung squamous cell carcinoma (LUSC), prostate adenocarcinoma (PAAD), and rectum adenocarcinoma (READ) (Figure 6A).